659. In Vitro Activity of Ceftazidime-Avibactam and Comparator Agents against Enterobacterales Collected from Patients with Bloodstream Infections (BSI) as Part of the ATLAS (India) Surveillance Program, 2019-2020

BACKGROUND: Ceftazidime-avibactam (CAZ-AVI) is indicated for patients with bacteremia that occurs in association complicated intra-abdominal infection (cIAI), complicated urinary tract infection (cUTI) and hospital-acquired pneumonia (HAP). The present report evaluated the in vitro activity of CAZ-A...

Descripción completa

Detalles Bibliográficos
Autores principales: Routray, Abhisek, Mane, Akshata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752292/
http://dx.doi.org/10.1093/ofid/ofac492.711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752292/
http://dx.doi.org/10.1093/ofid/ofac492.711

Ejemplares similares